Financial Survey: Forte Biosciences (NASDAQ:FBRX) versus Sycamore Entertainment Group (OTCMKTS:SEGI)

Sycamore Entertainment Group (OTCMKTS:SEGI) and Forte Biosciences (NASDAQ:FBRX) are both consumer discretionary companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, profitability, valuation, earnings, risk and institutional ownership.

Analyst Ratings

This is a summary of recent recommendations and price targets for Sycamore Entertainment Group and Forte Biosciences, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sycamore Entertainment Group	0	0	0	0	0.00
Forte Biosciences	0	0	3	0	3.00

Forte Biosciences has a consensus target price of $3.25, suggesting a potential downside of 32.29%. Given Forte Biosciences’ stronger consensus rating and higher probable upside, analysts plainly believe Forte Biosciences is more favorable than Sycamore Entertainment Group.

Volatility and Risk

Sycamore Entertainment Group has a beta of 49.22, suggesting that its stock price is 4,822% more volatile than the S&P 500. Comparatively, Forte Biosciences has a beta of 0.04, suggesting that its stock price is 96% less volatile than the S&P 500.

Insider and Institutional Ownership

77.6% of Forte Biosciences shares are owned by institutional investors. 75.5% of Sycamore Entertainment Group shares are owned by insiders. Comparatively, 9.6% of Forte Biosciences shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Profitability

This table compares Sycamore Entertainment Group and Forte Biosciences’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Sycamore Entertainment Group	N/A	N/A	N/A
Forte Biosciences	N/A	-117.85%	-98.67%

Valuation & Earnings

This table compares Sycamore Entertainment Group and Forte Biosciences”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sycamore Entertainment Group	N/A	N/A	N/A	N/A	N/A
Forte Biosciences	N/A	N/A	-$31.48 million	($18.25)	-0.26

About Sycamore Entertainment Group

Sycamore Entertainment Group, Inc., a diversified entertainment company, which specializes in the acquisition, marketing, and worldwide distribution of feature-length motion pictures. The company is based in Seattle, Washington.

About Forte Biosciences

Forte Biosciences, Inc. operates as a biopharmaceutical company in the United States. The company is developing FB-102 program that addresses various autoimmune diseases, such as graft-versus-host disease, and vitiligo and alopecia areata. Forte Biosciences, Inc. is headquartered in Dallas, Texas.